清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Impact of gut microbiota (GM) and antibiotic (ATB) use on immunotherapy efficacy in patients with lung cancer (LC): Preliminary results from a prospective trial.

医学 肺癌 抗生素 免疫疗法 癌症 内科学 肠道菌群 肿瘤科 临床试验 免疫学 微生物学 生物
作者
Gabriel Chagas Moreira,I. Borchardt,Gisele Farias,Francisca Dias,F Taveira,Wilza Arantes Ferreira Peres,Tatiane Montella,Carolina Alves Costa Silva,Carlos Gil Ferreira,Andréia Cristina de Melo
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:43 (16_suppl)
标识
DOI:10.1200/jco.2025.43.16_suppl.e20610
摘要

e20610 Background: LC is the leading cause of cancer death globally. Immune checkpoint inhibitors (ICI) have changed cancer treatment, but surpass resistance is still a challenge. The GM impact cancer immune-surveillance, and it can be modulated through diet/lifestyle and comedications (such as ATB). Microbiota-based biomarkers and interventions are promising strategies to overcome ICI resistance. We conducted a prospective trial (NCT04965129) to evaluate the impact of GM and ATB in non-small cell LC (NSCLC) patients (pts) treated with ICI. Methods: Pts with NSCLC eligible for ICI were assessed by monthly pharmaceutical visits and weekly telemonitoring to record the use of comedications up to 3 months before ICI start (T0) and from T0 to 4 months post-ICI start (T4), interaction assessment and pharmacotherapeutic follow-up. GM was analyzed at T0 and T4 by 16S rRNA sequencing. Alpha diversity was assessed using Shannon, Simpson, and InvSimpson indices; beta diversity by Bray-Curtis dissimilarity and differential relative frequency analysis using the Mann-Whitney test. Treatment response was evaluated according to RECIST v1.0, considering disease control (DC) if complete response, partial response, or stable disease. Results: We included 27 pts from February 2022 to February 2024: mean age of 70,6 years ± 7,5 [SD], mostly male (59%), with two or more comorbidities (63%), and polypharmacy (74%). Overall, 37% required pharmaceutical interventions and 47% used ATB. Progressive disease (PD) occurred in 88% of ATB users versus 12% of ATB non-users. ATB users and non-users did not differ in alpha or beta diversity. Clostridium difficile was detected in 75% of ATB users versus 0% non-ATB users. The relative frequency analysis brought up 8 species that significantly changed (p<0.05) between T0 and T4 among ATB users, including the pro- inflammatory Bacteroides clarus and Prevotella spp. Inversely, ATB non-users lost oral taxa Streptococcus spp. and gained the health-related Alistipes finegoldii . 81 species differed significantly between PD and DC (p<0.05) pts. All DC pts were positive for Akkermansia muciniphila versus 33% in PD pts, and they were enriched with health-related Lachnospiraceae (Roseburia spp., Blautia spp.) and Alistipes spp. Bacteroides caccae (p=0.035) and Prevotella copri (p=0.045) were present at TO and T4 in all patients. Conclusions: ATB use is associated to PD and pro-inflammatory taxa. Our study is a pioneer in the evaluation of Brazilian pts with LC treated with ICI. We contribute to equity and diversity in GM research towards more robust biomarkers for precision medicine. Clinical trial information: NCT04965129 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞快的蛋的应助被ay采纳,获得30
2秒前
5秒前
朴素的荧荧完成签到,获得积分10
9秒前
愉快的书桃完成签到,获得积分10
33秒前
加油完成签到 ,获得积分10
44秒前
pigff完成签到,获得积分10
44秒前
系统昵称完成签到,获得积分10
52秒前
白白完成签到,获得积分10
54秒前
黑大侠完成签到 ,获得积分0
1分钟前
如意大神完成签到,获得积分10
1分钟前
武安发布了新的文献求助10
1分钟前
波波波波波6764完成签到 ,获得积分10
1分钟前
欢呼的听枫完成签到,获得积分10
1分钟前
狞风妖完成签到 ,获得积分10
1分钟前
syvshc的应助被科研通管家采纳,获得10
2分钟前
俭朴竺完成签到,获得积分10
2分钟前
超男完成签到 ,获得积分10
2分钟前
丰富凌晴完成签到,获得积分10
2分钟前
Ahui完成签到 ,获得积分10
2分钟前
优雅的梦芝完成签到,获得积分10
2分钟前
温柔的谷冬完成签到,获得积分10
3分钟前
3分钟前
ww发布了新的文献求助10
3分钟前
小伟跑位完成签到,获得积分10
3分钟前
满意的平凡完成签到,获得积分10
3分钟前
奥丁不言语完成签到 ,获得积分10
3分钟前
哈哈哈哈哈完成签到,获得积分10
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
4分钟前
勤奋笙的应助被科研通管家采纳,获得10
4分钟前
幽默绝悟完成签到,获得积分10
4分钟前
北鲲居士完成签到,获得积分10
4分钟前
qianci2009完成签到,获得积分0
4分钟前
甜蜜的紫菜完成签到,获得积分10
4分钟前
舒心的瑾瑜完成签到,获得积分10
4分钟前
失眠紫完成签到,获得积分10
5分钟前
mousfy完成签到 ,获得积分10
5分钟前
5分钟前
YuLu完成签到 ,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185453
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834496
捐赠科研通 7783067
什么是DOI,文献DOI怎么找? 3434570
关于科研通互助平台的介绍 2558912
邀请新用户注册赠送积分活动 2481326